Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online therapy aims to help chronic pain sufferers accept and manage their pain

NCT ID NCT07270588

Symptom relief Sponsor: Catholic University of the Sacred Heart Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an internet-based guided self-help program for adults with chronic pain. The program uses Acceptance and Commitment Therapy (ACT) to help participants accept their pain and focus on meaningful activities. Over seven weeks, participants complete weekly online modules. The goal is to improve pain acceptance, quality of life, and daily functioning.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Internet-based guided self-help intervention based on Acceptance and Commitment Therapy (ACT)
What this could lead to
If it works, this could provide an accessible, low-cost way to help people with chronic pain manage their condition and improve their quality of life.
What could go wrong
This is a relatively small trial testing a behavioral intervention, so results may not apply to everyone. The program requires active participation and internet access, which may limit its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 18 years or older; 2. A verifiable medical diagnosis of Chronic Pain (duration ≥ 3 months); 3. Internet access; 4. Sufficient computer and internet literacy; 5. Fluent knowledge of the Italian language. Exclusion Criteria: 1. Current participation in psychological or psychotherapeutic treatments for chronic pain management; 2. High risk of suicide; 3. Cognitive impairments; 4. Presence of certified psychiatric disorders, such as: 1. Psychotic disorders (e.g., schizophrenia, schizoaffective disorders, etc.); 2. Bipolar disorder (unstabilized manic or hypomanic episodes); 3. Severe depressive disorders (e.g., major depression, suicidal intent, or recent suicide attempts); 4. Severe personality disorders that impair the ability to carry out daily activities (e.g., work, self-care); 5. Cognitive or neurodegenerative disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alma Mater Studiorum of Bologna

    RECRUITING

    Bologna, Italy

  • Catholic University of Sacred Heart

    RECRUITING

    Milan, Italy

  • University of Linkoping

    RECRUITING

    Linköping, Sweden

  • University of Verona

    RECRUITING

    Verona, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.